Isomorphic Labs Raises $5B in Latest Funding Round

Is AI drug design finally cracking problems that stalled medicine for decades or is it tech-bubble pricing for a company with no trials?
Isomorphic Labs Raises $5B in Latest Funding Round
Above: Demis Hassabis at the Cannes Lions 2026 in Cannes, France, on June 24. Image credit: Shane Anthony Sinclair/Getty Images for Cannes Lions

The Facts

  • AI drug discovery startup Isomorphic Labs announced on Tuesday that it raised $5 billion in a Series C funding round co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz among the new investors, alongside continued investment from Alphabet.
  • All existing investors participated in the oversubscribed round, including Thrive Capital, MGX, GV, CapitalG, Temasek and the U.K. Sovereign AI Fund. Isomorphic did not disclose a valuation, though Bloomberg previously reported it would raise it to around $50 billion.
  • The financing came six months after a $2.1 billion Series B funding round led by Thrive Capital in May and a $600 million round in March 2025, taking total external funding to roughly $7.7 billion.

Sources Split


The Spin


Pro-industry narrative

Investment in Isomorphic Labs is money well spent. Thanks to its revolutionary IsoDDE system, it can search chemical spaces for therapeutic and treatment advances that no human team could cover. Positive preclinical results in oncology and immunology show the models already deliver better molecules, opening the door to medical breakthroughs.

Industry-critical narrative

The rapid rise in Isomorphic Labs' valuation speaks volumes about the tech bubble, but little about biotech reality. After all, how can people believe a preclinical company with no clinical trials is worth the same as drugmakers pulling in billions in annual revenue? Investors piling in their cash are taking a massive risk based on minimal substance.


Metaculus Prediction


Go Deeper

AI: Health Care
AI: Health Care
Artificial Intelligence
Artificial Intelligence
© 2026 Improve the News Foundation. All rights reserved.Version 8.0.0

© 2026 Improve the News Foundation.

All rights reserved.

Version 8.0.0